NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 132 filers reported holding NOVOCURE LTD in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $401,000 | -90.9% | 3,600 | -93.9% | 0.12% | -68.9% |
| Q3 2019 | $4,414,000 | +34.7% | 59,024 | +13.9% | 0.38% | +47.9% |
| Q2 2019 | $3,277,000 | +30.2% | 51,824 | -35.6% | 0.26% | +41.2% |
| Q2 2018 | $2,517,000 | -16.7% | 80,423 | -42.0% | 0.18% | -19.8% |
| Q1 2018 | $3,022,000 | – | 138,620 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |